rethinkPeptides Search
Menu
Study breakdown

Discovery of a Heart-Specific Receptor for Growth Hormone Peptides That Protects Against Heart Attack Damage

Animal StudyModerate evidence
The takeaway

A new cardiac-specific GHRP receptor was identified that is distinct from the pituitary GH-releasing receptor, explaining how hexarelin protects hearts from ischemic damage independently of growth hormone.

Distinct cardiac receptor

The heart's GHRP receptor is different from the pituitary receptor, meaning cardiac protection is independent of growth hormone release

What the researchers found

A novel cardiac-specific GHRP receptor distinct from the pituitary GHS-R was identified in rat heart tissue, binding hexarelin with high affinity and mediating cardioprotective effects independently of GH release.

Why it matters

The discovery that the heart has its own GHRP receptor means GH secretagogues could be developed specifically for cardiac protection, separate from their GH-releasing effects. This opens a new therapeutic avenue for heart disease.

How the study worked

Animal study using radioligand binding on cardiac membranes from normal, GH-deficient, and senescent rats. Receptor specificity was determined by competition binding with various ligands. Functional cardioprotection was confirmed in isolated heart models.

What this study cannot tell us

Receptor identified in rat hearts; human cardiac receptor confirmation needed. The downstream signaling pathway was not fully characterized. In-vivo cardioprotective dose-response not established.

How to read the evidence

Moderate evidence from comprehensive binding studies with functional validation in isolated heart models, across multiple animal age groups.

When this study was published

Published in 1999. This cardiac GHRP receptor (later linked to CD36) has been further characterized, confirming the heart as a direct target for GH secretagogues.

The bigger picture

Heart disease is the leading cause of death worldwide. A peptide that directly protects the heart through its own receptor — separate from any GH effects — represents a fundamentally new approach to cardiovascular therapy.

Questions still open

  • Can this cardiac receptor be targeted with selective peptides for heart protection?
  • Does this receptor exist in human hearts?
  • Could GHRP analogs be developed that protect the heart without raising GH?

Common questions

Can growth hormone peptides protect the heart?
Yes. This study shows hexarelin protects hearts from damage after blood flow loss, and it does so through a unique heart receptor — not by raising growth hormone. This means the cardiac benefit is direct and independent.
Could this lead to new heart medications?
Potentially. A peptide that directly activates cardiac protective receptors could be developed as a treatment for heart attacks or heart failure, representing a completely new class of cardiovascular drugs.

Read the original research

Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.

Circulation research, 85(9), 796-802

Citation

Bodart, V; Bouchard, J F; McNicoll, N; Escher, E; Carrière, P; Ghigo, E; Sejlitz, T; Sirois, M G; Lamontagne, D; Ong, H. (1999). Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.. Circulation research, 85(9), 796-802.